Docking to RNA via root-mean-square-deviation-driven energy minimization with flexible ligands and flexible targets

被引:79
作者
Guilbert, Christophe [1 ]
James, Thomas L. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
关键词
D O I
10.1021/ci8000327
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-based drug design is now well-established for proteins as a key first step in the lengthy process of developing new drugs. In many ways, RNA may be a better target to treat disease than a protein because it is upstream in the translation pathway, so inhibiting a single mRNA molecule could prevent the production of thousands of protein gene products. Virtual screening is often the starting point for structure-based drug design. However, computational docking of a small molecule to RNA seems to be more challenging than that to protein due to the higher intrinsic flexibility and highly charged structure of RNA. Previous attempts at docking to RNA showed the need for a new approach. We present here a novel algorithm using molecular simulation techniques to account for both nucleic acid and ligand flexibility. In this approach, with both the ligand and the receptor permitted some flexibility, they can bind one another via an induced fit, as the flexible ligand probes the surface of the receptor. A possible ligand can explore a low-energy path at the surface of the receptor by carrying out energy minimization with root-mean-square-distance constraints. Our procedure was tested on 57 RNA complexes (33 crystal and 24 NMR structures); this is the largest data set to date to reproduce experimental RNA binding poses. With our procedure, the lowest-energy conformations reproduced the experimental binding poses within an atomic root-mean-square deviation of 2.5 angstrom for 74% of tested complexes.
引用
收藏
页码:1257 / 1268
页数:12
相关论文
共 68 条
  • [1] The process of structure-based drug design
    Anderson, AC
    [J]. CHEMISTRY & BIOLOGY, 2003, 10 (09): : 787 - 797
  • [2] Auerbach Tamar, 2002, Current Drug Targets - Infectious Disorders, V2, P169, DOI 10.2174/1568005023342506
  • [3] The Protein Data Bank
    Berman, HM
    Westbrook, J
    Feng, Z
    Gilliland, G
    Bhat, TN
    Weissig, H
    Shindyalov, IN
    Bourne, PE
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
  • [4] Interactions of the antibiotics neomycin B and chlortetracycline with the hammerhead ribozyme as studied by Zn2+-dependent RNA cleavage
    Borda, EJ
    Sigurdsson, ST
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (05) : 1023 - 1028
  • [5] Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171
  • [6] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [7] Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics
    Carter, AP
    Clemons, WM
    Brodersen, DE
    Morgan-Warren, RJ
    Wimberly, BT
    Ramakrishnan, V
    [J]. NATURE, 2000, 407 (6802) : 340 - 348
  • [8] Representing receptor flexibility in ligand docking through relevant normal modes
    Cavasotto, CN
    Kovacs, JA
    Abagyan, RA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (26) : 9632 - 9640
  • [9] Protein flexibility in ligand docking and virtual screening to protein kinases
    Cavasotto, CN
    Abagyan, RA
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2004, 337 (01) : 209 - 225
  • [10] Molecular biology of hepatitis D virus: Research and potential for application
    Chen, PJ
    Wu, HL
    Wang, CJ
    Chia, JH
    Chen, DS
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) : S188 - S192